These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3399065)

  • 1. Memory dysfunction in myasthenia gravis: evidence for central cholinergic effects.
    Tucker DM; Roeltgen DP; Wann PD; Wertheimer RI
    Neurology; 1988 Aug; 38(8):1173-7. PubMed ID: 3399065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
    Glennerster A; Palace J; Warburton D; Oxbury S; Newsom-Davis J
    Neurology; 1996 Apr; 46(4):1138-42. PubMed ID: 8780106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological function before and after plasma exchange in myasthenia gravis.
    Iwasaki Y; Kinoshita M; Ikeda K; Shiojima T; Kurihara T
    J Neurol Sci; 1993 Feb; 114(2):223-6. PubMed ID: 8445405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myasthenia gravis and sleep].
    Stepansky R; Zeitlhofer J
    Wien Klin Wochenschr; 2001 Apr; 113(7-8):285-7. PubMed ID: 11383390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory abnormalities in myasthenia gravis: possible fatigue of central nervous system cholinergic circuits.
    Davidov-Lusting M; Klinghoffer V; Kaplan-Dinur A; Steiner I
    Autoimmunity; 1992; 14(1):85-6. PubMed ID: 1299351
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive dysfunction in myasthenia gravis.
    Iwasaki Y; Kinoshita M; Ikeda K; Takamiya K; Shiojima T
    Int J Neurosci; 1990 Sep; 54(1-2):29-33. PubMed ID: 2265963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.
    Kaltsatou A; Fotiou D; Tsiptsios D; Orologas A
    BBA Clin; 2015 Jun; 3():299-303. PubMed ID: 26672759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of cognitive impairment in elderly myasthenia gravis patients.
    Marra C; Marsili F; Quaranta D; Evoli A
    Muscle Nerve; 2009 Dec; 40(6):952-9. PubMed ID: 19768771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of central functional cholinergic deficits in myasthenia gravis.
    Lewis SW; Ron MA; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):258-61. PubMed ID: 2703842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological performance in patients with myasthenia gravis].
    Eizaguirre MB; Aguirre F; Yastremiz C; Vanotti S; Villa A
    Medicina (B Aires); 2017; 77(2):117-120. PubMed ID: 28463217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptor turnover in myasthenia gravis.
    Appel SH; Blosser JC; McManaman JL; Ashizawa T
    Am J Physiol; 1982 Jul; 243(1):E31-6. PubMed ID: 7091363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory impairment in myasthenia gravis.
    Riker WF
    Neurology; 1989 Apr; 39(4):611-2. PubMed ID: 2927695
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of myasthenia gravis with dropped head: a report of 2 cases and review of the literature.
    Tamai M; Hashimoto T; Isobe T; Sato H; Doden T; Nakano T
    Neuromuscul Disord; 2015 May; 25(5):429-31. PubMed ID: 25747003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: a case series study.
    Yeh JH; Chen WH; Chiu HC; Lee CT; Hsu CY
    Artif Organs; 2010 Jun; 34(6):E200-3. PubMed ID: 20456321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.